Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lanreotide Autogel 120mg Dose-Interval Titration in Acromegaly
NCT00444873Phase 3Completed
- Sponsor
- Ipsen
- Start
- Jan 2005
- Primary completion
- Jan 2008
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of lanreotide in acromegaly, sponsored by Ipsen. Started Jan 2005; status: completed.
02
Drugs
lanreotide
03
Conditions
acromegaly
Beyond the preview
Go deeper on NCT00444873.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00444873.